Biodesix Inc
BDSXNasdaqCIK 1439725HealthcareFiscal year ends Dec 31
Reports and events: 118 filings
Newest first, by EDGAR acceptance time (Eastern). Each filing’s page lists its documents on sec.gov and, for 10-K and 10-Q reports, the extracted sections.
What the forms are: 10-K, 10-Q, 8-K, Form 4, DEF 14A, Schedule 13D, Schedule 13G, amendments, accession numbers.
| Filed | Form | What it is | Accession number |
|---|---|---|---|
| 2024-04-0916:07 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 5.03 Amendment to articles or bylaws; 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-24-090787 |
| 2024-03-0106:11 ET | 10-K | Annual reportPeriod 2023-12-31 | 0000950170-24-023513 |
| 2024-03-0106:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-24-023509 |
| 2023-12-2009:19 ET | 8-K | 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0000950170-23-071761 |
| 2023-11-0716:05 ET | 10-Q | Quarterly reportPeriod 2023-09-30 | 0000950170-23-060226 |
| 2023-11-0716:02 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-060209 |
| 2023-08-1116:31 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-23-039297 |
| 2023-08-0717:17 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-23-038377 |
| 2023-08-0717:07 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-23-038357 |
| 2023-08-0716:12 ET | 10-Q | Quarterly reportPeriod 2023-06-30 | 0000950170-23-039073 |
| 2023-08-0716:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-039049 |
| 2023-07-2616:07 ET | 8-K | 8.01 Other events; 9.01 Financial statements and exhibits | 0001193125-23-194600 |
| 2023-06-0616:26 ET | 8-K | 5.02 Departure or appointment of officers or directors; 9.01 Financial statements and exhibits | 0001193125-23-161649 |
| 2023-05-2516:15 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-23-154219 |
| 2023-05-1116:19 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-021281 |
| 2023-05-1116:11 ET | 10-Q | Quarterly reportPeriod 2023-03-31 | 0000950170-23-021238 |
| 2023-04-1216:05 ET | DEF 14A | Proxy statementPeriod 2023-05-23 | 0001193125-23-099181 |
| 2023-03-0606:11 ET | 10-K | Annual reportPeriod 2022-12-31 | 0000950170-23-006092 |
| 2023-03-0606:05 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-23-006084 |
| 2023-01-1316:30 ET | SC 13D | Ownership report, active investor | 0001140361-23-001651 |
| 2022-12-1616:06 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-22-026669 |
| 2022-12-0116:45 ET | SC 13D | Ownership report, active investor | 0001140361-22-044045 |
| 2022-11-2316:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-22-042999 |
| 2022-11-2316:30 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-22-042998 |
| 2022-11-2116:05 ET | 8-K | 1.01 Entry into a material agreement; 1.02 Termination of a material agreement; 2.03 New direct financial obligation; 3.02 Unregistered sale of equity; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-025530 |
| 2022-11-0306:13 ET | 10-Q | Quarterly reportPeriod 2022-09-30 | 0000950170-22-021488 |
| 2022-11-0306:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-021479 |
| 2022-10-1106:16 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-019405 |
| 2022-08-0406:16 ET | 10-Q | Quarterly reportPeriod 2022-06-30 | 0000950170-22-014433 |
| 2022-08-0406:07 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-014426 |
| 2022-05-2516:06 ET | 8-K | 5.07 Shareholder vote results; 9.01 Financial statements and exhibits | 0001193125-22-159676 |
| 2022-05-1106:16 ET | 10-Q | Quarterly reportPeriod 2022-03-31 | 0000950170-22-009126 |
| 2022-05-1106:06 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-009124 |
| 2022-04-1817:18 ET | SC 13D | Ownership report, active investor | 0001140361-22-014899 |
| 2022-04-1116:15 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-22-013979 |
| 2022-04-1106:06 ET | 8-K | 1.01 Entry into a material agreement; 3.02 Unregistered sale of equity; 8.01 Other events | 0000950170-22-005536 |
| 2022-03-3116:12 ET | DEF 14A | Proxy statementPeriod 2022-05-24 | 0001193125-22-091782 |
| 2022-03-1406:18 ET | 10-K | Annual reportPeriod 2021-12-31 | 0000950170-22-003495 |
| 2022-03-1406:12 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-003491 |
| 2022-03-0716:14 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-003002 |
| 2022-02-1409:55 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-001168 |
| 2022-02-1408:01 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0000950170-22-001157 |
| 2022-01-2817:23 ET | SC 13D/A | Ownership report, active investor, amended | 0000905148-22-000137 |
| 2022-01-0416:21 ET | SC 13D/A | Ownership report, active investor, amended | 0001140361-22-000504 |
| 2022-01-0416:06 ET | 8-K | 1.01 Entry into a material agreement; 8.01 Other events; 9.01 Financial statements and exhibits | 0000950170-22-000036 |
| 2021-12-0808:34 ET | 8-K | 5.02 Departure or appointment of officers or directors; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0000950170-21-005077 |
| 2021-11-1507:48 ET | 10-Q | Quarterly reportPeriod 2021-09-30 | 0001564590-21-056811 |
| 2021-11-1507:45 ET | 8-K | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001564590-21-056810 |
| 2021-09-0909:16 ET | 8-K | 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001564590-21-047416 |
| 2021-08-1016:11 ET | 10-Q | Quarterly reportPeriod 2021-06-30 | 0001564590-21-043081 |
Source: SEC EDGAR, the company’s filing index. Last ingested by Listed: Nov 12, 2026, 19:59 ET. Listed shows no prices and gives no investment advice.